News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
29,866 Results
Type
Article (2187)
Company Profile (1)
Press Release (27676)
Section
Business (7466)
Career Advice (193)
Deals (1160)
Drug Delivery (5)
Drug Development (1906)
Employer Resources (7)
FDA (859)
Job Trends (652)
News (11775)
Policy (976)
Tag
Academia (199)
Accelerated approval (2)
Adcomms (1)
Allergies (2)
Alliances (1892)
ALS (11)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (5)
Approvals (874)
Artificial intelligence (19)
Autoimmune disease (2)
Automation (3)
Bankruptcy (7)
Best Places to Work (517)
Biosimilars (4)
Biotechnology (1)
Bladder cancer (1)
Brain cancer (4)
Breast cancer (7)
Cancer (152)
Cardiovascular disease (19)
Career advice (171)
Career pathing (5)
CAR-T (4)
Cell therapy (11)
Clinical research (1620)
Collaboration (48)
Compensation (19)
Complete response letters (4)
COVID-19 (81)
CRISPR (2)
C-suite (24)
Data (203)
Depression (8)
Diabetes (32)
Diagnostics (181)
Digital health (4)
Drug discovery (8)
Drug pricing (4)
Drug shortages (2)
Duchenne muscular dystrophy (1)
Earnings (2321)
Editorial (2)
Employer branding (1)
Employer resources (6)
Events (3212)
Executive appointments (43)
FDA (984)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (54)
Gene editing (2)
Generative AI (1)
Gene therapy (15)
GLP-1 (78)
Government (172)
Guidances (19)
Healthcare (624)
Immunology and inflammation (2)
Immuno-oncology (1)
Indications (1)
Infectious disease (85)
Inflammatory bowel disease (3)
Influenza (2)
Intellectual property (6)
Interviews (37)
IPO (434)
Job creations (144)
Job search strategy (142)
JPM (2)
Labor market (2)
Layoffs (11)
Leadership (5)
Legal (225)
Liver cancer (6)
Longevity (1)
Lung cancer (10)
Lymphoma (22)
Machine learning (1)
Management (4)
Manufacturing (44)
MASH (7)
Medical device (1060)
Medtech (1061)
Mergers & acquisitions (755)
Metabolic disorders (103)
Multiple sclerosis (5)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (101)
NextGen: Class of 2026 (414)
Non-profit (267)
Obesity (64)
Opinion (15)
Ovarian cancer (3)
Pain (6)
Pancreatic cancer (16)
Parkinson's disease (18)
Partnered (1)
Patents (11)
Patient recruitment (7)
People (2595)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase 1 (474)
Phase 2 (718)
Phase 3 (525)
Pipeline (175)
Policy (5)
Postmarket research (64)
Preclinical (259)
Press Release (5)
Prostate cancer (23)
Radiopharmaceuticals (27)
Rare diseases (39)
Real estate (365)
Recruiting (2)
Regulatory (742)
Reports (1)
Research institute (162)
Resumes & cover letters (25)
Schizophrenia (2)
Series A (12)
Series B (3)
Sickle cell disease (4)
Spinal muscular atrophy (9)
Sponsored (2)
Startups (223)
Stomach cancer (1)
Supply chain (7)
Tariffs (2)
The Weekly (1)
Vaccines (19)
Weight loss (23)
Women's health (3)
Worklife (3)
Date
Last 7 days (24)
Last 30 days (69)
Last 365 days (977)
2026 (97)
2025 (979)
2024 (1151)
2023 (1419)
2022 (3684)
2021 (2439)
2020 (1868)
2019 (2163)
2018 (1668)
2017 (1271)
2016 (1397)
2015 (1831)
2014 (1380)
2013 (1294)
2012 (1322)
2011 (1360)
2010 (1026)
Location
Africa (56)
Alabama (1)
Alaska (1)
Arizona (5)
Asia (1745)
Australia (228)
California (300)
Canada (86)
China (33)
Colorado (12)
Connecticut (2)
Delaware (4)
Europe (3630)
Florida (97)
Georgia (14)
Idaho (3)
Illinois (28)
India (2)
Indiana (7)
Iowa (1)
Japan (13)
Kansas (5)
Maryland (48)
Massachusetts (193)
Michigan (34)
Minnesota (49)
Missouri (2)
Nevada (3)
New Hampshire (3)
New Jersey (92)
New York (77)
North Carolina (51)
North Dakota (1)
Northern California (190)
Ohio (27)
Oklahoma (1)
Oregon (2)
Pennsylvania (39)
Puerto Rico (2)
Rhode Island (4)
South America (88)
South Carolina (2)
Southern California (70)
Tennessee (2)
Texas (89)
United States (1242)
Utah (29)
Virginia (11)
Washington State (17)
West Virginia (1)
Wisconsin (17)
29,866 Results for "sapphire energy".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PHC Corporation of North America Launches TwinGuard® ECO 703VXH Freezer, Bringing New Energy Efficiency to Research Sample Protection
New ultra-low temperature (ULT) freezer builds on dual cooling system technology with new energy-saving design to support secure long-term sample storage while reducing cost of ownership.
January 15, 2026
·
1 min read
Press Releases
Pivotal SAPPHIRE Trial Data Published in The Lancet Neurology: Apitegromab Demonstrated Significant Motor Function Gains for Children and Adults with SMA on SMN-Targeted Treatment
August 15, 2025
·
10 min read
Press Releases
ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand
Transaction positions ENTO in the high-growth AI energy-infrastructure market, amid a surge of multi-billion-dollar hyperscaler spending on data centers, and rapid growth in behind-the-meter energy storage solutions
October 1, 2025
·
5 min read
Press Releases
Scholar Rock to Present Comprehensive Update at 2025 Annual Cure SMA Research and Clinical Care Meeting, Including Positive Results from Pivotal Phase 3 SAPPHIRE Trial
June 23, 2025
·
9 min read
Press Releases
Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
March 17, 2025
·
13 min read
Press Releases
Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway
June 16, 2025
·
4 min read
Radiopharmaceuticals
Perspective Therapeutics Brings Energy to the Radiopharma World
The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and speedy speech.
June 6, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Scholar Rock to Present Additional Clinical Data from the Phase 3 SAPPHIRE Trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
February 21, 2025
·
9 min read
Drug Development
Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial
Scholar Rock announced today that it has completed enrollment of the SAPPHIRE Phase 3 trial evaluating the safety and efficacy of apitegromab in nonambulatory patients with Types 2 and 3 spinal muscular atrophy (SMA) who are receiving SMN therapy (either nusinersen or risdiplam).
September 19, 2023
·
9 min read
Press Releases
Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis Patients
September 26, 2025
·
8 min read
1 of 2,987
Next
